Alto Neuroscience Inc.

ANRONYSEUSD
27.16 USD
1.57 (6.14%)AT CLOSE (11:59 AM EDT)
27.12
0.05 (0.17%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
27.12
0.05 (0.17%)
🔴Market: CLOSED
Open?$26.22
High?$28.44
Low?$25.96
Prev. Close?$25.59
Volume?335.6K
Avg. Volume?368.7K
VWAP?$27.39
Rel. Volume?0.91x
Bid / Ask
Bid?$25.00 × 200
Ask?$27.91 × 100
Spread?$2.91
Midpoint?$26.46
Valuation & Ratios
Market Cap?897.0M
Shares Out?31.9M
Float?22.4M
Float %?72.0%
P/E Ratio?N/A
P/B Ratio?5.93
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.69Strong
Quick Ratio?15.69Strong
Cash Ratio?15.58Strong
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
5.93FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-11.3CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-41.8%WEAK
ROA?
-34.2%WEAK
Cash Flow & Enterprise
FCF?$-51793000
Enterprise Value?$739.5M
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Employees
68
Market Cap
897.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012